FDA Adverse Event Malfunction Summary report: N

ANALYTICAL E MODULE

MDR report key: 3573140 · Received January 14, 2014

Report

Report Number
1823260-2014-00288
Event Type
Malfunction
Date Received
January 14, 2014
Date of Event
December 24, 2013
Report Date
March 4, 2014
Manufacturer
ROCHE DIAGNOSTICS
Product Code
NIG
PMA / PMN Number
K961481
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A DEFINITIVE ROOT CAUSE COULD NOT BE DETERMINED. THE PATIENT'S SAMPLE WAS TESTED USING THE CENTAUR METHOD WITH A 1:100 DILUTION AND THE RESULT WAS 18500 U/ML, WHICH WAS IN AGREEMENT WITH THE ELECSYS RESULT AT A 1:100 DILUTION. PER THE PACKAGE INSERT, THE CA 19-9 ANTIGEN TENDS TO AGGREGATE WHICH CAN LEAD TO NON-LINEAR DILUTION BEHAVIOR. THE ELECSYS RESULT WAS LIKELY CORRECT.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER ALLEGED THEY RECEIVED A QUESTIONABLE CARBOHYDRATE ANTIGEN 19-9 (CA 19-9) RESULTS FOR ONE PATIENT ON THEIR E-MODULE. THE CUSTOMER WOULD NOT PROVIDE THE SPECIFIC DATE OF THIS EVENT. THE PATIENT'S INITIAL RESULT WAS >1000 U/ML. THE SAMPLE WAS DILUTED 1:5 AND THE RESULT WAS 3268.5 U/ML. THE SAMPLE WAS DILUTED 1:10 AND THE RESULT WAS 5192 U/ML. THE SAMPLE WAS DILUTED 1:20 AND THE RESULT WAS 8042 U/ML. THE SAMPLE WAS DILUTED 1:100 AND THE RESULT WAS 15990 U/ML. THE SAMPLE WAS DILUTED 1:400 AND THE RESULT WAS 21392 U/ML. THE CUSTOMER WOULD NOT PROVIDE INFORMATION ON WHETHER ANY OF THE RESULTS WERE REPORTED OUTSIDE THE LABORATORY. THERE WERE NO DEATHS, INJURIES, ILLNESSES, OR DETERIORATIONS IN HEALTH ASSOCIATED WITH THE ERRONEOUS RESULTS. THE CUSTOMER WOULD NOT PROVIDE INFORMATION ON WHETHER THE PATIENT WAS HARMED BY ANY ACTIONS TAKEN. THE CA 19-9 REAGENT LOT NUMBER WAS 172934 AND THE EXPIRATION DATE WAS 12/30/2014.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
37105 ANALYTICAL E MODULE IMMUNOCHEMISTRY ANALYZER NIG ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1